GlaucomaNCT07153588
Awareness and Perception of Glaucoma Among Patients Attending Ophthalmology OPD in a Tertiary Care Hospital.
An observational study of Glaucoma, run by Bacha Khan Medical College at 1 site in Pakistan.
Trial summary
Glaucoma is often called the "silent thief of vision" because it can slowly damage the optic nerve and cause permanent blindness if it is not found and treated early. Many people are not aware of glaucoma, its risk factors, or the importance of regular eye checkups. Read more about this study
- Who is it for?
- Ages 18 to 80 yearsHealthy volunteers can take part
- Conditions the study is for
- Glaucoma
- What is being tested?
- Level of awareness
- How many people
- 379 participants
- Where
- 1 sitePakistan
- Study dates
- 28 Apr 2025to 5 Jun 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: The study population includes adult patients aged 18 to 80 years who attend the Ophthalmology Outpatient Department (OPD) at Mardan Medical Complex, a tertiary care teaching hospital in Khyber Pakhtunkhwa, Pakistan. Both new and follow-up patients are included, regardless of whether they have glaucoma or another eye condition. Participants come from a variety of backgrounds, with many residing in rural areas and a large proportion having limited or no formal education. Patients with diagnosed glaucoma, those with other ocular problems such as cataract or refractive errors, and individuals with systemic conditions like diabetes or hypertension are all eligible. Patients unable to provide informed responses due to cognitive impairment, mental illness, ocular malignancy, or active ocular bleeding are excluded.
Who may be able to join
- Adult patients between 18 and 80 years of age attending the Ophthalmology Outpatient Department (new or follow-up cases).
- Patients with ocular conditions, including diagnosed glaucoma and other eye pathologies.
Who cannot join
- Patients with cognitive impairment or mental illness that limits their ability to understand or respond to the questionnaire.
- Patients with ocular malignancy or active ocular bleeding.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Awareness and Perception of Glaucoma Among Patients Attending Ophthalmology OPD in a Tertiary Care Hospital: A Prospective Study.
Glaucoma is often called the "silent thief of vision" because it can slowly damage the optic nerve and cause permanent blindness if it is not found and treated early. Many people are not aware of glaucoma, its risk factors, or the importance of regular eye checkups.
This study is being conducted at the Ophthalmology Outpatient Department of Mardan Medical Complex, a large tertiary care hospital in Pakistan. The aim is to find out how much patients know and understand about glaucoma, and what beliefs or misconceptions they may have.
Read more
A total of 379 patients between the ages of 18 and 80 years will be asked to complete a simple questionnaire. The questions cover background information, eye history, knowledge about glaucoma, and attitudes toward screening and treatment. For patients who cannot read, trained staff will help them complete the questionnaire.
The information from this study will help doctors and health policy makers design better educational programs, improve public awareness, and encourage early eye screening. This can reduce the risk of irreversible vision loss caused by glaucoma
Read the detailed description
Glaucoma is the leading cause of irreversible blindness worldwide and is often described as the "silent thief of vision." Because it progresses slowly and early symptoms are often missed, many patients only seek medical care after significant vision has already been lost. Lack of awareness and misconceptions about glaucoma are major barriers to early diagnosis and treatment, particularly in low- and middle-income countries.
This study is designed to measure the awareness and perception of glaucoma among patients attending the Ophthalmology Outpatient Department of a tertiary care hospital in Mardan, Pakistan. Using a structured questionnaire, researchers will collect information on four domains:
Sociodemographic details (age, gender, education, occupation, residence, and family history of glaucoma)
Ocular history (previous eye disease, surgery, or diagnosis of glaucoma)
Awareness of glaucoma (understanding of risk factors, symptoms, and treatment)
Perceptions and attitudes (beliefs about curability, reversibility of vision loss, and willingness to undergo screening or learn more).
A total of 379 participants will be included, and assistance will be provided for patients who cannot read or write to ensure accurate responses. Statistical analysis will be used to identify patterns and factors associated with higher or lower awareness levels.
The findings are expected to highlight critical knowledge gaps, common misconceptions, and areas where targeted educational efforts are most needed. By identifying who is most at risk of poor awareness, this study will provide evidence for developing effective public health interventions, awareness campaigns, and screening programs. Ultimately, the results aim to support earlier diagnosis and better management of glaucoma, reducing preventable vision loss in the community.
- Conditions
- Glaucoma
- Being tested
- Level of awareness
- Medical subject headings
- Glaucoma
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Level of awarenessOther
This study uses a structured, interviewer-assisted questionnaire as the main intervention. The questionnaire is designed to assess patients' awareness and perception of glaucoma. It includes four sections:
Sociodemographic information (age, gender, education, occupation, residence, family history)
Ocular history (diagnosis of glaucoma, history of eye disease, surgery, or previous eye checkups)
Awareness of glaucoma (understanding of risk factors, symptoms, prevention, and treatment options)
Perceptions and attitudes (beliefs about curability, reversibility of vision loss, and willingness for screening and education).
For illiterate participants, trained research staff will administer the questionnaire verbally without influencing responses. The data collection method distinguishes this intervention from treatment-based studies, as it focuses on knowledge assessment and perception analysis rather than a medical or surgical procedure.
What is being measured
The primary outcome is the main question the study is designed to answer.
Level of Awareness about Glaucoma
Proportion of participants who demonstrate correct perception of glaucoma, defined as identifying it as a disease associated with increased intraocular pressure and risk of irreversible vision loss.
Measured: At the time of questionnaire completion (baseline, single visit)
Secondary outcomes (1)
Perception of Glaucoma and Its Curability
Percentage of participants who believe glaucoma is curable, reversible, or leads to permanent blindness.
Measured: (Baseline, single visit)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Sep 2025
- Study start28 Apr 2025
- Primary completion5 Jun 2025
- Study completion5 Jun 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for GlaucomaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 379 participants (actual)
Sponsor and investigators
- Lead sponsor
- Bacha Khan Medical College
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Malik Shayan Ali Khan, Bacha Khan Medical College
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07153588
- Sponsor's protocol ID
- Ref no. 771/BKMC
- Status last verified
- Aug 2025
- First submitted
- 25 Aug 2025
- Last updated
- 4 Sep 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 4 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Awareness and Perception of Glaucoma Among Patients Attending Ophthalmology OPD in a Tertiary Care Hospital: A Prospective Study.
- ClinicalTrials.gov ID
- NCT07153588
- Acronym / sponsor ID
- Ref no. 771/BKMC
- Conditions
- Glaucoma
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 379 participants (actual)
- Lead sponsor
- Bacha Khan Medical CollegeUniversity, hospital or other
- Study start
- 28 Apr 2025 (actual)
- Primary completion
- 5 Jun 2025 (actual)
- Study completion
- 5 Jun 2025 (actual)
- First posted
- 4 Sep 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Glaucoma is often called the "silent thief of vision" because it can slowly damage the optic nerve and cause permanent blindness if it is not found and treated early. Many people are not aware of glaucoma, its risk factors, or the importance of regular eye checkups.
This study is being conducted at the Ophthalmology Outpatient Department of Mardan Medical Complex, a large tertiary care hospital in Pakistan. The aim is to find out how much patients know and understand about glaucoma, and what beliefs or misconceptions they may have.
A total of 379 patients between the ages of 18 and 80 years will be asked to complete a simple questionnaire. The questions cover background information, eye history, knowledge about glaucoma, and attitudes toward screening and treatment. For patients who cannot read, trained staff will help them complete the questionnaire.
The information from this study will help doctors and health policy makers design better educational programs, improve public awareness, and encourage early eye screening. This can reduce the risk of irreversible vision loss caused by glaucoma
Detailed description
Glaucoma is the leading cause of irreversible blindness worldwide and is often described as the "silent thief of vision." Because it progresses slowly and early symptoms are often missed, many patients only seek medical care after significant vision has already been lost. Lack of awareness and misconceptions about glaucoma are major barriers to early diagnosis and treatment, particularly in low- and middle-income countries.
This study is designed to measure the awareness and perception of glaucoma among patients attending the Ophthalmology Outpatient Department of a tertiary care hospital in Mardan, Pakistan. Using a structured questionnaire, researchers will collect information on four domains:
Sociodemographic details (age, gender, education, occupation, residence, and family history of glaucoma)
Ocular history (previous eye disease, surgery, or diagnosis of glaucoma)
Awareness of glaucoma (understanding of risk factors, symptoms, and treatment)
Perceptions and attitudes (beliefs about curability, reversibility of vision loss, and willingness to undergo screening or learn more).
A total of 379 participants will be included, and assistance will be provided for patients who cannot read or write to ensure accurate responses. Statistical analysis will be used to identify patterns and factors associated with higher or lower awareness levels.
The findings are expected to highlight critical knowledge gaps, common misconceptions, and areas where targeted educational efforts are most needed. By identifying who is most at risk of poor awareness, this study will provide evidence for developing effective public health interventions, awareness campaigns, and screening programs. Ultimately, the results aim to support earlier diagnosis and better management of glaucoma, reducing preventable vision loss in the community.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- The study population includes adult patients aged 18 to 80 years who attend the Ophthalmology Outpatient Department (OPD) at Mardan Medical Complex, a tertiary care teaching hospital in Khyber Pakhtunkhwa, Pakistan. Both new and follow-up patients are included, regardless of whether they have glaucoma or another eye condition. Participants come from a variety of backgrounds, with many residing in rural areas and a large proportion having limited or no formal education. Patients with diagnosed glaucoma, those with other ocular problems such as cataract or refractive errors, and individuals with systemic conditions like diabetes or hypertension are all eligible. Patients unable to provide informed responses due to cognitive impairment, mental illness, ocular malignancy, or active ocular bleeding are excluded.
Key inclusion criteria (2 listed)
- Adult patients between 18 and 80 years of age attending the Ophthalmology Outpatient Department (new or follow-up cases).
- Patients with ocular conditions, including diagnosed glaucoma and other eye pathologies.
Key exclusion criteria (2 listed)
- Patients with cognitive impairment or mental illness that limits their ability to understand or respond to the questionnaire.
- Patients with ocular malignancy or active ocular bleeding.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Level of awarenessThis study uses a structured, interviewer-assisted questionnaire as the main intervention. The questionnaire is designed to assess patients' awareness and perception of glaucoma. It includes four sections: Sociodemographic information (age, gender, education, occupation, residence, family history) Ocular history (diagnosis of glaucoma, history of eye disease, surgery, or previous eye checkups) Awareness of glaucoma (understanding of risk factors, symptoms, prevention, and treatment options) Perceptions and attitudes (beliefs about curability, reversibility of vision loss, and willingness for screening and education). For illiterate participants, trained research staff will administer the questionnaire verbally without influencing responses. The data collection method distinguishes this intervention from treatment-based studies, as it focuses on knowledge assessment and perception analysis rather than a medical or surgical procedure. | Other | – |
Primary outcome
Level of Awareness about Glaucoma
Time frame: At the time of questionnaire completion (baseline, single visit)
Proportion of participants who demonstrate correct perception of glaucoma, defined as identifying it as a disease associated with increased intraocular pressure and risk of irreversible vision loss.
1 secondary outcome
Perception of Glaucoma and Its Curability
Time frame: (Baseline, single visit)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Sep 2025.
Related trials for Glaucoma
Recruiting
Implementing AI-based Glaucoma Screening Within Federally Qualified Health Centers
Glaucoma, Ocular Hypertension
Not yet recruiting
AI-Assisted vs Conventional Teleglaucoma Referral
Glaucoma
Recruiting
Brain Stimulation Effects on Orientation and Mobility Skills in Adults With Vision Impairment
Retinitis Pigmentosa (RP), Rod Cone Dystrophy
Recruiting
Automated Applanation Tonometry - Updated
Glaucoma, Glaucoma, Suspect
RecruitingPhase 2
A Phase 2a Study Comparing the Efficacy, Safety and Tolerability of Pregabalin Eye Drops Comparing With Timolol Eye Drops in Adults With Glaucoma or High Eye Pressure.
Primary Open - Angle Glaucoma (POAG), Ocular Hypertension (OHT)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Glaucoma, run by Bacha Khan Medical College at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 4 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Level of Awareness about Glaucoma (time frame: At the time of questionnaire completion (baseline, single visit)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Sep 2025.